The analysis of Iran’s enriched uranium situation reveals a steady 42% chance for the country to surrender its stockpile by December 31, 2026. This figure remains unchanged from prior assessments. However, the likelihood of reaching a US-Iran nuclear deal by May 31, 2026, has declined to 17.5%, indicating a gap in confidence for a swift resolution.
Former U.S. President Donald Trump has reinforced his commitment to Israeli Prime Minister Benjamin Netanyahu, asserting that Iranian uranium enrichment will not be tolerated. The backdrop for these negotiations involves U.S. and Israeli military interventions aimed at curbing Iran's nuclear capabilities. Under the current proposal, Iran would be permitted to recommence its uranium enrichment after a decade-long halt, contrasting sharply with Trump’s unwavering stance against any form of Iranian enrichment.
Key figures such as Steve Witkoff and Jared Kushner are actively engaged in discussions aimed at compelling Iran to export its enriched uranium stockpile in return for sanctions relief. The pivotal role of Trump’s agreement underscores the potential escalations should negotiations stall, with the Israeli Defense Forces bracing for the prospect of renewed conflict.
Market indicators reflect this dynamic situation. While there is still a 42% probability for Iran to consent to surrender its enriched uranium by the deadline, the diminished odds of achieving a nuclear agreement by late May suggest waning optimism in the market. Current geopolitical tensions continue to influence these perceptions, with negotiations ongoing.
Investors should keep a close eye on developments in the U.S.-Iran discussions. Any formal communications from Trump, Netanyahu, or Iranian officials will be critical. Furthermore, monitoring the International Atomic Energy Agency’s reports on Iran’s compliance and inspection results can shed light on the feasibility of reaching a consensus. New sanctions or military actions could significantly impact market expectations and valuations.